Felix Deanda

665 citations

13 papers · 487 indexed · h-index 11

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 7
- HIV Research and Treatment 7
Infectious Diseases 6
- HIV/AIDS drug development and treatment 6

Co-authors: Mark Underwood Kendra E. Hightower Brian A. Johns Wieslaw M. Kazmierski Kurt Weaver Takahiro Seki Masanori Kobayashi Hanbiao Yang
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)Bioorganic & Medicinal Chemistry (1 paper)Journal of Biological Chemistry (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: United States Japan Switzerland

In The Last Decade

Felix Deanda

13 papers receiving 471 citations

Peers

Countries citing papers authored by Felix Deanda

Since Specialization

Citations

This map shows the geographic impact of Felix Deanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Deanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Deanda more than expected).

Fields of papers citing papers by Felix Deanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Deanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Deanda. The network helps show where Felix Deanda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Felix Deanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Felix Deanda Line = papers co-authored together Felix Deanda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation Journal of Biological Chemistry ·Greg L. Beilhartz, P Favard, Brian A. Johns, Felix Deanda, Peter Gerondelis, Matthias Götte	2014	25
2	Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics PLoS ONE ·Felix Deanda, Kendra E. Hightower, Robert T. Nolte, Kazunari Hattori, Tomokazu Yoshinaga, Takashi Kawasuji, Mark Underwood	2013	44
3	Prevalent Polymorphisms in Wild-Type HIV-1 Integrase Are Unlikely To Engender Drug Resistance to Dolutegravir (S/GSK1349572) Antimicrobial Agents and Chemotherapy ·Cindy Vavro, Samiul Hasan, Ante Ćorluka, Joseph Horton, Felix Deanda, Matevž Vodopivec, Akihiko Sato, Robert L. Cuffe, Shuguang Chen, Mark Underwood, Garrett Nichols	2013	17
4	Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats Bioorganic & Medicinal Chemistry Letters ·Maosheng Duan, Wieslaw M. Kazmierski, Pek Y. Chong, Felix Deanda, Mark Edelstein, R M Ferris, J. Piñas Massó, Pat Wheelan, Zhiping Xiong, Luciano Hommers Júnior, Máirín Brown, Yoshikazu Takaoka	2011	9
5	Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes Antimicrobial Agents and Chemotherapy ·Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yujun Zhu, Jon Suzuki, H. Luke Carter, 邓安强, 其谁林, Takahiro Seki, Masanori Kobayashi, Mark Underwood	2011	182
6	Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Samarjit Patnaik, Kirk L. Stevens, Ruyu Yan, Felix Deanda, J. Brad Shotwell, Jun Tang, 大熊宏, Hiroko Nakamura, M. Anthony Leesnitzer, Anne M. Hassell, Anne Bucher, Rakesh Kumar, Huangshu Lei, Stanley D. Chamberlain	2009	20
7	Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: Elimination of an acid-mediated decomposition pathway Bioorganic & Medicinal Chemistry Letters ·Stanley D. Chamberlain, Anikó M. Redman, Samarjit Patnaik, M. Zhai, Nicholas Syrotiuk, Felix Deanda, Ruyu Yan, Huangshu Lei, Ganesh S. Moorthy, Kamilova Adiba Zakirzhonovna, Kirk L. Stevens, Joseph W. Wilson, J. Brad Shotwell	2008	15
8	Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Stanley D. Chamberlain, Joseph W. Wilson, Felix Deanda, Samarjit Patnaik, Anikó M. Redman, Bin Yang, Lisa M. Shewchuk, Peter Sabbatini, M. Anthony Leesnitzer, Arthur Groy, Charity Atkins, Ruyu Yan, Anne M. Hassell, Huangshu Lei, Robert A. Mook, Ganesh S. Moorthy, Jason L. Rowand, Kirk L. Stevens, Rakesh Kumar, J. Brad Shotwell	2008	27
9	Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1 Journal of Medicinal Chemistry ·Wieslaw M. Kazmierski, Christopher Aquino, Brian A. Chauder, Felix Deanda, Robert G. Ferris, Michael Stoldt, Terrence Kenakin, Cecilia S. Koble, Christian Watson, Pat Wheelan, Hanbiao Yang, E. Ejiri	2008	26
10	Kinase-Targeted Library Design through the Application of the PharmPrint Methodology Journal of Chemical Information and Modeling ·Felix Deanda, Eugene L. Stewart, Michael J. Reno, David H. Drewry	2008	15
11	Aza-stilbenes as potent and selective c-RAF inhibitors Bioorganic & Medicinal Chemistry Letters ·Octerloney B. McDonald, Karen Lackey, Ronda G. Davis‐Ward, Edgar R. Wood, Vicente Sámano, Patrick Maloney, Felix Deanda, R. Hunter	2006	14
12	Application of the PharmPrint Methodology to Two Protein Kinases Journal of Chemical Information and Computer Sciences ·Felix Deanda, Eugene L. Stewart	2004	8
13	Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors Bioorganic & Medicinal Chemistry ·Wieslaw M. Kazmierski, Neil Bifulco, Hanbiao Yang, A-u-Zaman, Felix Deanda, Chris Watson, Terry Kenakin	2003	85

About Felix Deanda

Felix Deanda is a scholar working on Virology, Infectious Diseases, Computational Theory and Mathematics, Endocrinology, Diabetes and Metabolism and Biophysics, having authored 13 papers that have together received 487 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers), Biochemical and Molecular Research (4 papers), Computational Drug Discovery Methods (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Click Chemistry and Applications (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Virology (289 citations), Infectious Diseases (321 citations), Molecular Biology (221 citations), Organic Chemistry (78 citations) and Computational Theory and Mathematics (34 citations). Felix Deanda has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Mark Underwood, Kendra E. Hightower, Brian A. Johns, Wieslaw M. Kazmierski, Kurt Weaver, Takahiro Seki, Masanori Kobayashi, Hanbiao Yang, H. Luke Carter and Ruolan Wang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact